Table 1.
Participant Characteristics
| Characteristic | EA (n = 45,645) | AA (n = 7,597) | HE (n = 2,493) |
|---|---|---|---|
| Age, years (mean ± SD) | 49.0 ± 14.1 | 43.6 ± 12.5 | 41.1 ± 13.2 |
| Female, n (%) | 25,301 (55.4) | 5245 (69.0) | 1590 (63.8) |
| Diabetes, n (%) | 3388 (7.4) | 875 (11.5) | 292 (11.7) |
| Hypertension, n (%) | 5561 (12.2) | 1086 (14.3) | 246 (9.9) |
| Hypercholesterolemia, n (%) | 9702 (21.3) | 1200 (15.8) | 552 (22.1) |
| Statin use, n (%) | 12,521 (27.4) | 1045 (13.8) | 201 (8.1) |
| Incident CHD events, n (%) | 2221 (4.9) | 311 (4.1) | 120 (4.8) |
| Age at incident CHD event, years (mean ± SD) | 59.5 ± 9.5 | 56.0 ± 10.4 | 57.9 ± 10.1 |
| Prevalent CHD cases, n (%) | 5887 (12.9) | 527 (6.9) | 299 (12.0) |
| Follow-up in years, median (IQR) | 11.7 (6.0–18.5) | 9.2 (5.5–13.0) | 10.4 (5.7–14.7) |
| Person years | 595,896 | 75,370 | 27,191 |